| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $287.9M | -28.8% |
| Cost of Revenue | $22.5M | -6.4% |
| R&D Expense | $27.6M | -13.0% |
| SG&A Expense | $26.3M | -6.4% |
| Operating Income | -$52.0M | -109.7% |
| Pre-tax Income | -$50.7M | -107.7% |
| Income Tax | $577K | — |
| Net Income | -$51.3M | -110.1% |
| EPS (Basic) | -$1.54 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.0M | +23.1% |
| Accounts Receivable | $21.2M | -28.5% |
| Current Assets | $69.2M | -14.5% |
| Total Assets | $110.9M | -29.1% |
| Current Liabilities | $29.9M | -34.0% |
| Total Liabilities | $30.0M | -38.8% |
| Stockholders' Equity | $80.9M | -24.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.8M | +82.1% |
| Investing Cash Flow | $9.4M | +318.0% |
| Financing Cash Flow | $577K | -96.4% |
| -100.0% |
| EPS (Diluted) | -$1.54 | -100.0% |